TGTX
TG THERAPEUTICS, INC.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Operating Income
$123.3M
↑ 194.1%
Net Income
$447.2M
↑ 1812.4%
Revenue
$616.3M
↑ 87.3%
EPS (Diluted)
$2.77
↑ 1746.7%
Total Assets
$1.1B
↑ 84.1%
Total Liabilities
$415.2M
↑ 16.9%
Cash & Equivalents
$79.1M
↓ 56.0%
Shareholders' Equity
$648.0M
↑ 191.4%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 3/27/2026 View on SEC
8-K 3/20/2026 View on SEC
10-K 2/27/2026 View on SEC
8-K 2/26/2026 View on SEC
4 1/29/2026 View on SEC
8-K 1/13/2026 View on SEC
4 1/9/2026 View on SEC
4 1/9/2026 View on SEC
4 11/25/2025 View on SEC
144 11/24/2025 View on SEC

Company Information

Field Value
Ticker TGTX
Company Name TG THERAPEUTICS, INC.
CIK 1001316
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (212) 554-4484